Why the study?
Does valsartan inhibit Angiotensin II-induced EMMPRIN expression in atherosclerotic plaques in ApoE knockout mice?
Does valsartan inhibit Angiotensin II-induced EMMPRIN expression in atherosclerotic plaques in ApoE knockout mice?
Angiotensin II upregulates EMMPRIN expression in atherosclerotic plaques via AT1R, an effect that can be inhibited by valsartan, providing a potential mechanism for plaque stabilization.
Answers are grounded in this paper and cite their sources.
Valsartan inhibits Ang II-induced EMMPRIN in mouse plaques; leaves open human plaque stabilization relevance.
UNLABELLED: The pathogenesis of acute coronary syndrome is rupture of vulnerable plaque. Extracellular matrix metalloproteinase inducer (EMMPRIN) is reported to have a important role in the destabilization of atheroma. OBJECTIVES: this investigation examined the effect of angiotensin II (Ang II) on EMMPRIN expression in atherosclerotic plaques in ApoE knockout mice. METHODS: ApoE knockout mice were fed a high fat diet to establish an atherosclerosis model then intervention was made with Ang II and valsartan. EMMPRIN gene and its protein expression were measured by real-time PCR immunohistochemistry, and Western blot. RESULTS: EMMPRIN gene and protein expression intervened with Ang II were significantly increased; valsartan could inhibit the effect of Ang II. CONCLUSION: Ang II up-regulated EMMPRIN expression in atherosclerotic plaque via AT1R, and valsartan could inhibit the effect of Ang II.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: